United States:
New York's Frankenstein Zoning Rules Creates Monster Problems For City Laboratories
13 January 2021
Kramer Levin Naftalis & Frankel LLP
To print this article, all you need is to be registered or login on Mondaq.com.
Land Use partner Elise Wagner and special counsel Patrick
Sullivan's article, "New York's Frankenstein Zoning
Rules Creates Monster Problems for City Laboratories" appeared
in Crain's New York on Jan. 7, 2021. The
article focuses on how updating New York's zoning rules to make
life sciences development less cumbersome would help to maximize
the industry's potential in New York City.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from United States
FDA Ramps Up Actions On PFAS
Holland & Knight
The U.S. Food and Drug Administration (FDA) has increased regulatory activity with regard to per- and polyfluoroalkyl substances (PFAS).
Planning For The BIOSECURE Act
Foley Hoag LLP
Bipartisan legislation moving through the U.S. House and Senate, known as the BIOSECURE Act, could limit the ability of U.S. life sciences companies...
